Clinical pharmacology and pharmacogenetic study on the clinical response for tamoxife

Not Applicable

• Conditions: Breast cancer

• Registration Number: JPRN-UMIN000001411
• Lead Sponsor: Saitama Medical University, Saitama International Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-10-03
• Study Completion: 2013-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1. Tamoxifen contraindication. Patients with (possibly) pregnant, with lactation. Patients possibly suffering from allergic reaction, severe liver or kidney dysfunction. 2. Patients who are judged by doctors as inadequate to enroll this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pharmacokinetics of tamoxifen and metabolites. Efficacy and side effects.